Prevalence, Frequency and Cost of Self-Monitoring of Blood Glucose and Its Influencing Factors for Insulin-Treated Diabetes Patients in China

H. Li,Z. Ruan,X. D. Guan,Z. G. Guo,F. Sun,L. W. Shi
DOI: https://doi.org/10.1016/j.jval.2014.03.1441
IF: 5.156
2014-01-01
Value in Health
Abstract:To describe the prevalence, frequency and cost of SMBG, and explore the factors that influence SMBG for insulin-treated diabetes patients in China. A questionnaire-based survey was conducted in 7 medical centres across China from June to September of 2012. Type 1 and type 2 diabetes patients treated with insulin were included in the study. The data were analysed by descriptive analysis, Spearman correlation analysis, K-W and M-W U test using SPSS 19.0. 602 eligible respondents (4.98% type 1 and 95.02% type 2 diabetes patients) were included. 85.0% of patients practiced SMBG with the frequency of 0.61±0.94 times/day. Among type 1 and type 2 diabetes patients, the prevalence and frequency of SMBG were 90.0% and 1.05 times/day, 84.8% and 0.59 times/day, respectively. Taking global recommended SMBG frequency into account, only 18.76% of type 2 diabetes patients conducted SMBG ≥1 time/day, and 7.4% of type 1 diabetes patients conducted SMBG ≥3 times/day. Annual cost of SMBG was 1170 CNY, estimated by the market price of 5 CNY/test trip. 20.5% of patients thought the cost of test trips was the most important factor to SMBG use. SMBG frequency was statistically and positively correlated with frequency and doses of insulin daily use, frequency and related cost of hypoglycaemia, drug cost, frequency and cost of hospitalization and clinical visit, with P-value <0.05. SMBG was not conducted enough in insulin-treated diabetes patients in China. Economic burden of test trips was one of the main barriers to SMBG use. Factors influencing SMBG included insulin use, hypoglycaemia, drug costs, frequency and cost of hospitalization and clinic visit.
What problem does this paper attempt to address?